1. Agúndez, J.A.G, Ledesma, M.C, Ladero, J.M. and Benítez, J. (1995) Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population. Clin Pharmacol Ther 57:265–269.
2. Albano, E., Clot, P., Morimoto, M., Tornasi, A., Ingelman-Sundberg, M. and French, S. (1995) Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol. Hepatology 23:155–163.
3. Aklillu, E., Persson, I., Bertilsson, L., Johansson, I., Rodrigues, F. and Ingelman-Sundberg, M. (1996) Frequent distribution of ultrarapid metabolizers of debrisoquine in an Ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharm Exp Ther 278:441–446.
4. Bertilsson, L., Dahl, M.-L., Sjöqvist, F., Åberg-Wistedt, A., Humble, M., Johansson I., Lundqvist, E. and Ingelman-Sundberg, M. (1993) Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine. Lancet 341: 63.
5. Bertilsson, L., Dahl, M.-L., Ingelman-Sundberg, M., Johansson, I. and Sjöqvist, F. (1995) Inter individual and interethnic differences in polymorphic drug oxidation - implications for drug theraphy with focus on psychoactive drugs. In: Advances in Drug Metabolism in Man, (Pacifici, G. and Fracchia, G.N., Eds), EUR 15439 EN, EC, DGXII-E-4, Luxembourg, office for publications of the European Commission, pp. 85–136.